InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement. Recently, H.R. 5371, the ‘Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and…
The Bank of Canada Governing Council met on Wednesday (December 10) for the final rate-setting meeting of 2025 and…
(TheNewswire) Vancouver, Canada, December 12, 2025 TheNewswire – Spartan Metals Corp. (‘ Spartan ‘ or the ‘ Company ‘)…
Rio Silver Inc. (the ‘Company’ or ‘Rio Silver’) (TSX.V: RYO,OTC:RYOOF) (OTC: RYOOF) announces that, following regulatory approval, the closing…
(TheNewswire) VANCOUVER TheNewswire – December 11, 2025 Providence Gold Mines Inc. (TSX-V: PHD) (‘ Providence ‘ or the ‘…
Locksley Resources Ltd. (ASX: LKY,OTC:LKYRF; OTCQX: LKYRF) announced the company has formally commenced the engineering partner selection process for…
Standard Uranium Ltd. (TSXV: STND,OTC:STTDF) (OTCQB: STTDF) (FSE: 9SU0) (‘Standard Uranium’ or the ‘Company’) announces the conclusion, effective December 11, 2025,…